Download Citation
Article Source:
Efficacy and safety of moderate-intensity rosuvastatin plus ezetimibe versus high-intensity rosuvastatin monotherapy in the treatment of composite cardiovascular events with hypercholesterolemia: A meta-analysis
Liu L,
Deng Y,
Li L,
Yang X,
Yin Z,
et al.
(2024)
Efficacy and safety of moderate-intensity rosuvastatin plus ezetimibe versus high-intensity rosuvastatin monotherapy in the treatment of composite cardiovascular events with hypercholesterolemia: A meta-analysis.
PLOS ONE 19(11): e0310696.
https://doi.org/10.1371/journal.pone.0310696